Implication of the RAGE-EN-RAGE axis in endometriosis
Other
OA: closed
CC0
⤵ 7 in-corpus citations
AI-generated summary
This study found significantly increased mRNA and protein expression of COX-2, RAGE, and EN-RAGE in endometriotic cells compared to control cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To investigate the involvement of the receptor gene for advanced glycation (RAGE), its ligand EN-RAGE, and COX-2 in endometriosis.
METHODS: The mRNA and protein expression of the corresponding genes were determined from endometriotic cells from 28 study patients and healthy endometrial stromal cells from 20 controls by semiquantitative RT-PCR and Western blot analysis, respectively, using beta-actin as an invariant control.
RESULTS: The expression of COX-2, RAGE, and EN-RAGE was significantly increased, as evidenced by the significantly greater mRNA and protein expression in the cells of the study patients (P<0.001). Previous treatment for endometriosis did not lessen mRNA and protein expression (P<0.001).
CONCLUSION: Our findings strengthen the hypothesis of an underlying inflammation in the pathophysiology of endometriosis and suggest exploring anti-inflammatory therapies as adjunct treatment.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (24)
- Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico-pathological parameters via openalex
- Concentrations of receptor for advanced glycation end products, VEGF and CML in plasma, follicular fluid, and peritoneal fluid in women with and without endometriosis via openalex
- Cyclooxygenase-2 regulates survival, migration, and invasion of human endometriotic cells through multiple mechanisms via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- Endometriosis via openalex
- Endometriosis and inflammation in infertility via openalex
- Expression of glycodelin and cyclooxygenase-2 in human endometrial tissue following three-dimensional culture via openalex
- Expression of inducible microsomal prostaglandin E synthase in local lesions of endometriosis patients via openalex
- Macrophages, oxidation, and endometriosis via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Role of 8-iso-prostaglandin F2alpha and 25-hydroxycholesterol in the pathophysiology of endometriosis via openalex
- W4211081176 via openalex
- W1207740807 via openalex
- W4249442256 via openalex
- W1976389947 via openalex
- W2001822779 via openalex
- W2002513475 via openalex
- W2011988431 via openalex
- W2049619918 via openalex
- W2071675524 via openalex
- W2117511353 via openalex
- W2123274778 via openalex
- W2135935849 via openalex
- W2159339965 via openalex
Cited by (8)
- Multi-Target Anti-Endometriosis Mechanisms of Camellia sinensis Polyphenols: An Integrated Computational and Transcriptomic Study 2026
- Multicenter evaluation of blood-based biomarkers for the detection of endometriosis and adenomyosis: A prospective non-interventional study 2023
- Does the Use of the "Proseek® Multiplex Inflammation I Panel" Demonstrate a Difference in Local and Systemic Immune Responses in Endometriosis Patients with or without Deep-Infiltrating Lesions? 2023
- Higher fibrotic content of endometriotic lesions is associated with diminished prostaglandin E2 signaling 2021
- Towards an understanding of the molecular mechanisms of endometriosis-associated symptoms (Review) 2020
- Plasma High Mobility Group Box 1 (HMGB1), Osteopontin (OPN), and Hyaluronic Acid (HA) as Admissible Biomarkers for Endometriosis 2019
- Hormonal therapy deregulates prostaglandin-endoperoxidase synthase 2 (PTGS2) expression in endometriotic tissues 2013
- New insights into pattern recognition receptors and their ligands in gynecologic pathologies 2010
Source provenance
- europepmc
- last seen: 2026-10-11T09:27:45.537177+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:07:39.929932+00:00
- unpaywall
- last seen: 2026-10-11T06:28:45.473802+00:00
License: CC0
· commercial use OK